The Journal of Immunology, Vol 138, Issue 11 3776-3784, Copyright © 1987 by American Association of Immunologists

ARTICLES

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross- specificity among TMEV substrains and related picornaviruses, but not myelin proteins

SD Miller, RJ Clatch, DC Pevear, JL Trotter and HL Lipton

Following intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV), susceptible mouse strains develop a chronic demyelinating disease characterized by mononuclear cell-rich infiltrates in the central nervous system. Current evidence strongly supports an immune-mediated basis for myelin breakdown, with an effector role proposed for TMEV-specific, major histocompatibility class II-restricted delayed-type hypersensitivity, which temporally correlates with disease onset and remains chronically elevated in susceptible mice. This study examined the fine specificity of class II- restricted T cell responses in TMEV-infected mice to better define the relevant virus-encoded T cell determinant(s) responsible for triggering the demyelinating process, and to determine if class II-restricted neuroantigen-specific autoimmune responses could be detected in mice with TMEV-induced demyelination. The data clearly show that T cell responses in TMEV-infected mice are directed against determinants shared by closely related TMEV strains and are cross-reactive with related picornaviruses, such as encephalomyocarditis virus. In contrast, class II-restricted autoimmune responses against syngeneic mouse spinal cord homogenate and the two major protein components of myelin, myelin basic protein and proteolipid protein, are not demonstrable in susceptible SJL/J mice undergoing chronic TMEV-induced demyelinating disease, but are readily seen in SJL/J mice displaying chronic, relapsing experimental allergic encephalomyelitis. Cross- reactivity (or lack thereof), as determined by functional T cell analyses, was found to correlate with the extent of exact amino acid homology between the TMEV capsid proteins, the two neuroantigens, and related picornaviruses. The data thus do not support a major role for autoimmune responses against myelin proteins in TMEV-induced demyelinating disease, but are consistent with our previously proposed hypothesis that TMEV-specific T cell responses constitute a major effector mechanism of myelin breakdown.

This article has been cited by other articles:

				A. M. Ercolini and S. D. Miller Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease J. Immunol., March 15, 2006; 176(6): 3293 - 3298. [Abstract] [Full Text] [PDF]

				M. L. Jelachich and H. L. Lipton Theiler's Murine Encephalomyelitis Virus Induces Apoptosis in Gamma Interferon-Activated M1 Differentiated Myelomonocytic Cells through a Mechanism Involving Tumor Necrosis Factor Alpha (TNF-{alpha}) and TNF-{alpha}-Related Apoptosis-Inducing Ligand J. Virol., July 1, 2001; 75(13): 5930 - 5938. [Abstract] [Full Text] [PDF]

				Y. Katz-Levy, K. L. Neville, J. Padilla, S. Rahbe, W. S. Begolka, A. M. Girvin, J. K. Olson, C. L. Vanderlugt, and S. D. Miller Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler's Virus-Infected Mice J. Immunol., November 1, 2000; 165(9): 5304 - 5314. [Abstract] [Full Text] [PDF]

				K. L. Neville, M. C. Dal Canto, J. A. Bluestone, and S. D. Miller CD28 Costimulatory Blockade Exacerbates Disease Severity and Accelerates Epitope Spreading in a Virus-Induced Autoimmune Disease J. Virol., September 15, 2000; 74(18): 8349 - 8357. [Abstract] [Full Text]

				A. Inoue, C.-S. Koh, M. Yamazaki, and H. Yagita Effect of Anti-B7-1 and Anti-B7-2 mAb on Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease J. Immunol., December 1, 1999; 163(11): 6180 - 6186. [Abstract] [Full Text] [PDF]

				R. K. Burt, J. Padilla, M. C. Dal Canto, and S. D. Miller Viral Hyperinfection of the Central Nervous System and High Mortality After Hematopoietic Stem Cell Transplantation for Treatment of Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease Blood, October 15, 1999; 94(8): 2915 - 2922. [Abstract] [Full Text] [PDF]

				M. L. Jelachich, C. Bramlage, and H. L. Lipton Differentiation of M1 Myeloid Precursor Cells into Macrophages Results in Binding and Infection by Theiler's Murine Encephalomyelitis Virus and Apoptosis J. Virol., April 1, 1999; 73(4): 3227 - 3235. [Abstract] [Full Text]

				A. Inoue, C.-S. Koh, M. Yamazaki, H. Yahikozawa, M. Ichikawa, H. Yagita, and B. S. Kim Suppressive Effect on Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease by the Administration of Anti-IL-12 Antibody J. Immunol., November 15, 1998; 161(10): 5586 - 5593. [Abstract] [Full Text] [PDF]

				W. S. Begolka, C. L. Vanderlugt, S. M. Rahbe, and S. D. Miller Differential Expression of Inflammatory Cytokines Parallels Progression of Central Nervous System Pathology in Two Clinically Distinct Models of Multiple Sclerosis J. Immunol., October 15, 1998; 161(8): 4437 - 4446. [Abstract] [Full Text] [PDF]

				J. G. Pope, C. L. Vanderlugt, S. M. Rahbe, H. L. Lipton, and S. D. Miller Characterization of and Functional Antigen Presentation by Central Nervous System Mononuclear Cells from Mice Infected with Theiler's Murine Encephalomyelitis Virus J. Virol., October 1, 1998; 72(10): 7762 - 7771. [Abstract] [Full Text] [PDF]